Skip to main content
. 2022 Oct 11;2:129. doi: 10.1038/s43856-022-00195-4

Fig. 6. Longitudinal antibody responses to SARS-CoV-2 in serum samples from six study participants, normalized temporally to the first day of positivity by RT-qPCR.

Fig. 6

Blue, IgG; red, IgA; green, IgM. A subject 2; B subject 21; C subject 38; D subject 48; E subject 83, with gray box identifying timepoint post-immunization with Ad26.COV2.S vaccine (Research name: JNJ-78436735, Janssen Pharmaceutical Companies, also known as the Johnson and Johnson vaccine); F subject 84.